Cargando…
Efficacy and Safety of Pergoveris in Assisted Reproductive Technology—ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatment
INTRODUCTION: The results of a recent meta-analysis showed that adding recombinant human luteinising hormone (r-hLH) to recombinant human follicle-stimulating hormone (r-hFSH) for ovarian stimulation was beneficial in poor responders, resulting in a 30% relative increase in the clinical pregnancy ra...
Autores principales: | Humaidan, P, Schertz, J, Fischer, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499676/ https://www.ncbi.nlm.nih.gov/pubmed/26141305 http://dx.doi.org/10.1136/bmjopen-2015-008297 |
Ejemplares similares
-
The Effects of Adiponectin on Infertile Women Undergoing IVF/ICSI Treatment and on Human Granulosa Cells
por: Qin, Lixian, et al.
Publicado: (2021) -
In assisted reproduction by IVF or ICSI, the rate at which embryos develop to the blastocyst stage is influenced by the fertilization method used: a split IVF/ICSI study
por: Speyer, Barbara, et al.
Publicado: (2019) -
Induced endometrial trauma (endometrial scratch) in the mid-luteal menstrual cycle phase preceding first cycle IVF/ICSI versus usual IVF/ICSI therapy: study protocol for a randomised controlled trial
por: Pye, Clare, et al.
Publicado: (2018) -
Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF/ICSI: A meta-analysis
por: LUO, SHAN, et al.
Publicado: (2014) -
Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Broekmans, Frank, et al.
Publicado: (2021)